U.S.SEC Chairman Christopher Cox:Samaritan Pharmaceuticals,a Georgetown University,James Angel Penny Stock Fraud


Georgetown U's James Angel a fraud as well

Georgetown University's James Angel knows that NCANS or National Coalition Against Naked Shorting (and thesanitycheck.con website),that he did a video 'misinfomercial' for in which he fraudulently claimed that 'naked short selling' was a serious problem for the worthless penny stock frauds they promote(and 'dump' or sell to naive investors), was and is an ongoing fraud that includes Georgetown University's neighbor James Dale Davidson,(founder of the National Taxpayers Union of Alexandria,Virginia where the main office of the U.S. SEC is coincidentally headquartered),who helped create NAANSS or the National Association Against Naked Short Selling before that to divert attention from his Genemax and Endovasc 'biotech' pump and dump frauds along with Brent Pierce's and Grant Atkins,(convicted Canadian penny stock con artists),ICI or Investor Communications International !

And now I discover that a Janet Greeson who received free shares of the worthless Endovasc penny stock scam of Stanford University's Chris Heeschen,John Cooke and law professor Joseph Grundfest to dump in 2000,(that attorney Houston attorneys John O'Quinn and James Wes Christian as well as James Dale Davidson,et.al. lied about being a victim of 'naked short selling' to cover up illegal offshore stock manipulation and probable money laundering)),is, along with her son,among the chief beneficiaries of the Georgetown University and Samaritan Pharmaceuticals penny stock pump and dump fraud !

Where's the Georgetown University professor and Securities Exchange Commission 'cyber fraud' czar John Reed Stark who is supposed to stop this endless daisy chain of internet penny stock fraud ? I wonder if he (John Reed Stark)has to hide the wretched truth of his penny stock fornicating with Georgetown University's James Angel from his wife and if SEC Chairman Christopher 'Naked Shorts' Cox(who lied about WMDS in Iraq sending thousands to their deaths and leaving even more permanently wounded), approves of this internet penny stock porn issuing from both the National Taxpayers Union and Georgetown University ?

biz.yahoo.com/pz/070808/124548.html

Press Release Source: Samaritan Pharmaceuticals, Inc.

Georgetown University and Samaritan Sign Exclusive Licensing Agreement for Novel Treatment of Cushing's Syndrome
Wednesday August 8, 9:52 am ET

LAS VEGAS, Aug. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV - News), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with Georgetown University for a new innovative drug SP-6300 to treat Cushing's syndrome.
Cushing's syndrome, sometimes called ``hypercortisolism,'' is a hormonal disorder caused by prolonged exposure of the body's tissues to high levels of the stress hormone called cortisol. Long-term (chronic) use of corticosteroid medications, for the treatment of conditions such as lupus, asthma, and rheumatoid arthritis, is the most common cause of Cushing's syndrome. Patients who develop Cushing's exhibit a variety of symptoms including weight gain, fatigue, muscle weakness, diabetes, high blood pressure, depression, and osteoporosis. If left untreated, Cushing's syndrome can lead to death.

See peer reviewed journal publications: www.samaritanpharma.com/publications_and_patents.asp

Source: Samaritan Pharmaceuticals, Inc.
............................................................................

www.secinfo.com/dUuzd.4w.htm

60. On or about February 2, 2000, we issued 25,000 (Endovasc) shares of our common
stock to Janet Greeson, in exchange for consulting services. Such shares were
valued at $0.40 per share and were issued pursuant to the exemption from
registration under Section 4(2) of the Securities Act of 1933, as amended.


www.prnewswire.com/cgi-bin/stories.pl=

Samaritan Positioned As 'Force' in the Treatment of Alzheimer's by CEO Greeson at Annual Meeting of Shareholders

SAMARITAN PHARMACEUTICALS CORPORATE LOGO
Samaritan Pharmaceuticals, in collaboration with Georgetown University, develops and strives to commercialize scientific breakthrough innovations for: Alzheimer's (AD) Drugs, to inhibit glucocorticoid-mediated neurotoxicity, an Animal Model to test AD drugs, an AD Diagnostic; a Breast Cancer Diagnostic; a peptide to bind Cholesterol and a late stage Phase II statistically significant HIV drug. Samaritan's patented pipeline is built on a, cholesterol-metabolism and glucocorticoid-biosynthesis, technology platform which is scientifically considered to be a successful therapeutic approach. (PRNewsFoto)[AS]
LAS VEGAS, NV USA


LAS VEGAS, July 2 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals Inc.
(OTC Bulletin Board: SPHC) and Samaritan Research Labs, Georgetown University,
announced today it has completed licensing of several new discoveries for
Alzheimer's, under its Georgetown University collaboration with Samaritan
Labs. Samaritan is well-positioned to become a "force" in the treatment of
Alzheimer's with breakthrough compounds that could change the way patients are
treated today, Chairman and Chief Executive Officer, Dr. Janet Greeson, said
at the company's 2003 Annual Meeting of Shareholders.
Speaking to shareholders at one of the largest shareholders meeting to
date, Greeson noted that the combination of Samaritan Pharmaceuticals and
Georgetown University brings more than seven technologies into Samaritan,
rapidly moving along "a continuum of development" to drive valuation and
increase shareholder value. The continuum for value begins with "in vitro"
studies and ends with the more advanced "proof of concept" Phase II studies in
humans, to test a drug's safety and its ability to prolong lives.
"The research collaboration with Georgetown University has not only given
us a chance to dramatically increase our technology valuation but also
strengthened every aspect of, an already strong expertise with business
development, intellectual property, regulatory affairs, and governmental
grants," said Greeson.

Greeson identified seven priority areas for the upcoming year
1. Promising Alzheimer's Drug Candidates
2. Stem Cell Therapy for Alzheimer's, Neuron Differentiation Drug
3. New Alzheimer's Pharmacologic (Rat) Model
4. AIDS Related Dementia Drug and Orphan Drug Status Request
5. HIV "Proof of Concept" Phase II to be submitted to FDA for End of PII
meeting
6. BioTerrorism Nerve Gas Inhibitor
7. Samaritan Innovative Science Foundation

Greeson continued, "We are dedicated to driving valuation and will
continue to aggressively 'bridge' technology from Georgetown University to
potential pharmaceutical partners throughout the year."
We are happy to announce the following directors were elected into Class
II term expiring 2006: Eugene Boyle, Brian Sullivan and Cynthia Thompson and
the following directors were elected into Class III term expiring 2005,
Douglas Bessert, H. Thomas Winn, and Vassilios Papadopoulos.
In other voting, shareholders approved an increase in authorized shares to
200 million shares and the selection of Sherb and Company, as our independent
auditor for 2003.

About Samaritan Pharma: "A Little Bridge Can Go a Long Way"
Samaritan Pharmaceuticals, in collaboration with Georgetown University,
drives to "bridge the gap" between Universities and potential Pharmaceutical
partners. Samaritan advances and accelerates clinical drug testing, to "proof
of concept" in humans, thereby, lessening the time breakthrough drugs reach
suffering Alzheimer's, Cancer, Cardiovascular, and HIV patients. Samaritan's
proprietary platform is based on balancing and modulating the stress hormone
cortisol, counteracting cortisol's neurodegenerative and immunosuppressive
properties.

Disclaimer
The company disclaims any information that is created by an outside party
and endorses only information that is communicated by its press releases,
filings and Web site. This news release contains forward-looking statements
that reflect management's current beliefs about the potential for its drug
candidates, science and technology. However, as with any biopharmaceutical
under development, there are significant risks and uncertainties in the
process of development and regulatory review. There are no guarantees that
products will prove to be commercially successful. For additional information
about the factors that affect the company's business, please read the
company's latest Form 10-K filed May 15, 2003. The company undertakes no duty
to update forward-looking statements.

(Photo: www.newscom.com/cgi-bin/prnh/20030129/SPHCLOGO )

For further information, please contact: Gene Boyle, Business
Development, 1-702-735-7001, or 1-702-499-8652, or fax, 1-702-737-7016,
GeneBoyle (at) aol.com, or Doug Bessert, Investor Relations, DougBessert (at) aol.com,
both of Samaritan Pharmaceuticals Inc.

To receive future press releases and newsletters automatically, or for
more information, visit our Web site at www.samaritanpharmaceuticals.com .

SOURCE Samaritan Pharmaceuticals Inc.
............................................................................

Samaritan Pharmaceuticals: ``Transforming Today's Science Into Tomorrow's Cures...''

Samaritan Pharmaceuticals is a life science company focused on commercializing its pipeline of innovative drugs to relieve the suffering of patients with Alzheimer's, cancer, heart disease, and infectious disease. Samaritan's business strategy is to partner drug candidates in its pipeline after Phase II (proof of concept) human studies. Samaritan has executed its first partnering agreement with Pharmaplaz, Ireland for its PII, HIV drug SP-01A. In addition, Samaritan's sales arm has acquired the marketing and sales rights to sell ten revenue-generating products in Greece and various Eastern European countries.

Website, www.samaritanpharma.com. Please register so we can notify you of upcoming conference calls, news and events.

The Samaritan Pharmaceuticals Inc. logo is available at www.primenewswire.com/newsroom/prs/

Disclaimer

The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings, and Website. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science, and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed April 13, 2007. The company undertakes no duty to update forward-looking statements.

Contact:
Samaritan Pharmaceuticals, Inc.
Richard Brown
(702) 735-7001
RichardBrown (at) SamaritanPharma.com


messages.finance.yahoo.com/Stocks_(A_to_Z)/Stocks_S/threadview?m=tm&bn=23238&tid=6999&mid=7004&tof=5&rt=2&frt=2&off=1

Re: Penny Stock Scams- Circular Trading - Notice there is no stock available to short (17 Ratings) 6-Jul-07 04:04 pm Old, but, sadly, still true:

Facts about Samaritan

1) The CEO has run several major scams before, including a $100 million fraud against insurance companies that left many people with unwarranted medical records. She is not a "Dr." despite the fact that she calls herself one. She has a PhD from a shut-down diploma mill. In SEC documents and other bios she falsely claims (among other things): to have received a presidential appointment from Jimmy Carter, to be an associate professor at several universities, and to have received a degree in restaurant/hotel management from a school that has never existed.

2) Her son, also possessing bogus degrees from an online law school, is the CFO and COO.

3) The company has around 10 employees. At least 4 of the people on the payroll are related to each other and live at the same address.

4) The market cap is now about $36 million. They have gone through over $150 million in funds.

5) They do not employ a single medical doctor or person qualified to develop drugs. Their chief drug development officer is a pharmacist who never had a "Dr." in his title until he landed at LIV, and who has a shaky professional history of his own.

6) Every drug they claim "in development" is either in pre-clinical stage (12 years away from market) or has been abandoned.

7) Every drug they have in development is essentially a mixture of commonly available substances that have no valuable properties for the diseases they are "developing" them for. A product known as �Gerovital,� also a mixture of procaine hydrochloride and vitamins, is already available.

8) They do not own the rights to and have been denied a �use patent� for the one substance (a "food product" in Nevada) currently undergoing early Phase II FDA testing (4 years after Phase I, in a different category, with no published results). LIV falsely advertised this product for years as having completed Phase II.

9) The company sold unregistered securities to SteinMorgan, a boilerroom operation that has been busted many times for illegal sales and tactics.

Facts that are second-hand but not disputed:

10) There is a substantial connection between the CEO and the Church of $cientology, widely regarded as an international criminal organization that specializes in money-laundering.

11) They have misused shareholder money in various ways, including lavish month-long trips to Europe on the excuse of presenting at a 1-day conference. The mother-and-son team is paid $765,000 a year in salary alone.

12) Georgetown professors are paid to add their name to the company and to add Greeson's name to junk research performed years ago. They are not conducting any experiments that could benefit Samaritan shareholders. There is no such thing as �Samaritan Research Laboratories,� despite references in the press and SEC documents.

13) Their so-called �charitable foundation� has no funding from the corporation and no intent other than to garner misleading publicity for the company.

Conclusion: The entire company is a scam. There is no intention to ever develop a worthwhile drug. They only want to release press releases, pump the stock, and live fat and happy on investor dollars until the company goes bankrupt.

-- Adapted and updated from a March '06 post by Hoostocks.

Call the schools, check the companies, email the Carter Library, look in Lexis/Nexis, contact the Council on Foundations, peruse Guidestar, phone Georgetown (202.687.0100). Ask questions, probe for proof, and then share your findings. Scams hurt everyone.

...........................................................................................................

Pluristem Placentas,James Dale Davidson,Leumi Bank Israel Holocaust Victims,U.S.Penny Stock Fraud

israel.indymedia.org/newswire/display/7200/index.php

WTC,9/11,Logan Airport, Boston:Israeli ICTS 'Security':Barney Frank,Ted Kennedy, John F. Kerry Face Psych Crisis

www.arkansas.indymedia.org/newswire/display/21040/index.php

Reuters on Security Exchange Commission Chairman Christopher Cox's Terrorist List

www.portland.indymedia.org/en/2007/07/361996.shtml

Boston Logan Airport,9/11,WTC,Barney Frank,SEC,Israeli Penny Stock Scam and Bloody Murder

www.austin.indymedia.org/newswire/display/35916/index.php

Max Keiser ,Al Jazeera,Qatar promote Naked U.S. Penny Stock Fraud

www.indymedia.org.uk/en/2007/06/373856.html

SEC'S Christopher'WMDS'Cox:Georgetown University James Angel Pimps Pink Sheet Penny Stock

www.portland.indymedia.org/en/2007/05/360325.shtml

Ex U.S. Treasury Secretary John Snow,Michael Moore, Cerberus,Bawag Austria and Cuba

www.portland.indymedia.org/en/2007/05/359319.shtml

Charles Schwab,Mantas 'AML':Did The CIA's SRA International Eat George W Bush's E-mail ?

www.indybay.org/newsitems/2007/04/28/18406278.php

U.S. Ambassador Sam Fox:From Swift Boat War Fraud to Brussels,Belgium SWIFT Finance Fraud

www.portland.indymedia.org/en/2007/04/357306.shtml

Israeli pResident Moshe Katsav's Penny Stock Partner Michael Zwebner loses in U.S. Court

www.melbourne.indymedia.org/news/2007/03/142021.php

Cryptometrics:New Zealand Passport Office Used By U.S. Penny Stock Criminals ?

www.indymedia.org.uk/en/2007/02/362828.html

David Grin,Tel Aviv University,Laurus Capital Management and Union Bank of Israel

www.israel.indymedia.org/newswire/display/6079/index.php

FOIA,Alberto Gonzales and SEC'S Chris Cox Enron,Merrill Lych,Latham & Watkins conflict

www.cleveland.indymedia.org/news/2007/01/24225.php

Tim Mahoney,vFinance,Venus Methodist Church,Florida,Sayed Mustafa and Islamic Usury

www.maritimes.indymedia.org/news/2006/12/15025.php

Charles Schwab:vFinance's Charles Patrick Garcia receives Henry B. Gonzalez award !?

www.indybay.org/newsitems/2006/12/24/18340307.php

Democrats William Jefferson,Tim Mahoney, iGate,vFinance,DOBI, Endovasc penny stock frauds

www.ntimc.org/newswire.php

James Dale Davidson,Charles Schwab,Tim Mahoney,VFIN, LOM and penny stock share money laundering

www.phillyimc.org/en/2006/12/34919.shtml

Ireland Indymedia bans criticism of Lord Rees Mogg,James Dale Davidson

www.southafrica.indymedia.org/news/2006/11/11701.php

Post to Lord Rees-Mogg's Weblog re NASDAQ,London Stock Exchange

www.posting.beirut.indymedia.org/ar/2006/11/5982.shtml

Virginia:Marvin Bush,Securacom,9/11,U.S. Senator George Allen,Bawag Austria,offshores...

www.southafrica.indymedia.org/news/2006/10/11458.php

U.S. Republican George Allen More Corrupt Than Utah Senators Bob Bennett,Orrin Hatch ?

www.southafrica.indymedia.org/news/2006/10/11391.php

Asa Hutchinson,Charlie Crist,Jeb Bush,Republican stock fraud and drug trafficking,etc....

www.houston.indymedia.org/news/2006/10/52801.php

Why did Osama bin Laden choose Jeb Bush's Huffman Aviation terrorist flight school ?

www.austin.indymedia.org/newswire/display/34636/index.php

Senator Bennett :Is Patrick Byrne's NCANS a Fraud ?

www.utah.indymedia.org/news/2005/10/11883_comment.php

Utah Gov Jon Huntsman,Senator Bennett, Hatch call Republican Senator Shelby 'a gangster'

www.la.indymedia.org/news/2006/09/179748.php

Does NY Times censor 9/11 Venice,Florida connection ?

www.utah.indymedia.org/news/2006/05/14058.php

NY Rep.Peter King,CIA,Swift,NY Times,Republican stock fraud

www.utah.indymedia.org/news/2006/06/15693_comment.php

NY WTC 'protected' by Kuwaiti company and Marvin Bush on 9/11

www.dc.indymedia.org/newswire/display/132705/index.php

Asa Hutchinson,Richard Rainwater,George W Bush,Tom DeLay & 5.6 Ton cocaine bust in Mexico

www.arkansas.indymedia.org/newswire/display/19870/index.php

SEC,Schwab,Chris Cox,Hillary Clinton & Barbara Boxer Aid CIA'S In-Q-Tel penny stock fraud

www.indybay.org/newsitems/2006/05/22/18246601.php

Senator Bennett :Is Patrick Byrne's NCANS a Fraud ?

www.utah.indymedia.org/news/2005/10/11883_comment.php

Cocaina,Ciudad Del Carmen,Campeche, Abril 10,CIA,Republicanos Y PAN

www.la.indymedia.org/news/2006/07/167389.php

Did Israel President Moshe Katsav aid Muslim Terrorism or only fraud ?

www.sbindymedia.org/newswire/display/3226/index.php

Israel: Gal Lusky's 'IFA' Caught Up in Moshe Katsav,Mohamed Hadid, Zwebner 'UCSY' scam ?

www.chapelhill.indymedia.org/news/2006/03/19255.php

Israeli President Moshe Katsav aids massive penny stock fraud

www.israel.indymedia.org/newswire/display/4195/index.php

Did Israel President Moshe Katzav aid Muslim Terrorism or only fraud ?

www.ntimc.org/newswire.php

SEC,Schwab,Chris Cox,Hillary Clinton & Barbara Boxer Aid CIA'S In-Q-Tel penny stock fraud

www.indybay.org/news/2006/05/1824660.php

Chris Cox,SEC,Makram Majid Chams,Titan Corp,9/11,Abhu Ghraib,etc.

www.maineindymedia.org/newswire/display/3952/index.php

SEC Covers Up UAE Money Laundering with U.S. Stocks

www.ucimc.org/newswire/display/112399/index.php

Time Magazine, Daniel Kadlec duped by Houston attorneys Wes Christian and John O'Quinn

www.cleveland.indymedia.org/news/2005/11/17786.php

John Reed Stark UAE,SEC,Georgetown University Stock fraud Academic fraud Cyber fraud

www.maritimes.indymedia.org/news/2006/03/12190.php

Does NSA Serve SRA International's 'Cookies' ?

www.india.indymedia.org/en/2005/12/211284.shtml

Porter Goss: CIA Cyber and stock fraud ops damaged by leaks ?

www.news.com.com/5208-1028-0.html;

D.C.Terrorbaggers:James Dale Davidson,Don Nickles, ex-CIA Chief Woolsey,Asa Hutchinson,Tom McMillen

www.okimc.org/newswire.php

Asa Hutchinson,ex Congressman Tom McMillen, Fortress America,offshore money laundering

www.cleveland.indymedia.org/news/2006/03/19034.php

To CIA,In-Q-Tel,Amit Yoran re SRA International, Mantas Inc stock fraud money laundering

www.maritimes.indymedia.org/news/2006/02/11841.php

Mantas Inc,Herndon, Va, Pro-Money Laundering Arm of International Bankers,Brokers...

www.ftaaimc.org/en/2005/12/7186.shtml

CIA and Gilman Louie are less than honest

www.news.com.com/5208-1082-0.html

Charles Schwab and Share-Money Laundering

www.indybay.org/newsitems/2005/06/12/17471071.php